soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction The (Semaglutide Trial) was a randomized, double-blind, placebo-controlled cardiovascular outcomes trial that enrolled 9,650 patients aged 50 years or older with Oral Semaglutide Gets FDA Approval
Description
Beyond your weight, we also track your body fat percentage, muscle mass, and total body water

Which medications are approved for obesity and weight management

Texas patients should increase water intake, eat smaller meals, and avoid high-fat or greasy foods to minimize gastrointestinal discomfort

Exogenous GLP-1 has the potential to normalize fasting and PPG levels in patients with T2D

While Medicares expansion will bring GLP-1s to millions, it will also push them further into the mainstreamleaving longevity enthusiasts and precision-health users to seek flexibility elsewhere

A balanced diet emphasizing whole grains, lean proteins, vegetables, and healthy fats supports both glycemic control and weight management